Susquehanna Portfolio Strategies’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Susquehanna Portfolio Strategies's ATRC Position: Q2 2026 in Review
Susquehanna Portfolio Strategies opened a new position in AtriCure (ATRC) in Q2 2026: 80,089 shares worth $2.24M. The stake represents 0.04% of the portfolio and ranks #423 among its holdings. This is a return to the name: Susquehanna Portfolio Strategies previously reported a position in ATRC as recently as Q4 2025.
Susquehanna Portfolio Strategies first reported a position in ATRC in Q4 2023 and has held it in 3 quarters since. The position peaked at $3.42M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Susquehanna Portfolio Strategies held 80,089 shares of AtriCure worth $2.24M as of Q2 2026.
- AtriCure was a new Susquehanna Portfolio Strategies position in Q2 2026.
- AtriCure made up 0.04% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #423 holding.
- Susquehanna Portfolio Strategies first reported a position in AtriCure in Q4 2023 and has held it in 3 quarters since.
- Susquehanna Portfolio Strategies's AtriCure position peaked at $3.42M in Q4 2025.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.